SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially launched their AR MRI Simulator to market. SpellBound’s MRI Simulator is designed to reduce the high sedation rates for pediatric magnetic resonance imaging (MRI) scans by acclimating children to the experience in a way that is fun and interactive.
The evolution from standalone PACS to extensive Enterprise Imagining Solutions created the need to archive information on a single platform, interoperable with various PACS silos. Explore features and benefits provided by today’s VNAs. Discover key considerations when selecting a VNA solution, ensuring your choice accommodates past, present, and future facility needs.
The Society for Imaging Informatics in Medicine (SIIM) and the American College of Radiology (ACR) are collaborating with the Society of Thoracic Radiology (STR) and MD.ai to host a Machine Learning Challenge on Pneumothorax Detection and Localization on Kaggle. The challenge will use augmented annotations on the public chest radiograph dataset from the National Institutes of Health (NIH). The augmented annotations were created by radiologists from SIIM and STR using a commercial web-based tool from MD.ai, and follow the ACR Data Science Institute’s structured artificial intelligence (AI) use case for pneumothorax detection.
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward, Calif. The 50,000 square-foot facility includes six state-of-the-art linear accelerator testing vaults for the RefleXion machine and will house manufacturing, quality control, and a customer education center with a radiation oncology suite for clinical training.
The ASRT Foundation and Canon Medical Systems are now accepting applications for the 2019 Safety FiRsT grant program, an initiative that provides funds for radiologic technologists to improve workplace safety measures.
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting 2019, held May 31 – June 4 in Chicago. The accepted abstract highlights the feasibility of AI-based biomarkers in metastatic non-small cell lung cancer, based on the H&E analysis that predicts response to immune checkpoint inhibitors (ICI).
